Home » Newsletters » The Carlat Psychiatry Report

The Carlat Psychiatry Report

Treatment-Resistant Depression (July/August) | 2018

View Archived Issues

CME Post-Test - Treatment-Resistant Depression, TCPR, July/August 2018

July 1, 2018

The post-test for this issue is available for one year after the publication date to subscribers only. By successfully completing the test you will be awarded a certificate for 2 CME credits. Read More

Welcoming Our New Editor-in-Chief

July 1, 2018

We’re pleased to introduce Chris Aiken, MD, as the new editor-in-chief of The Carlat Psychiatry Report. Dr. Aiken is a clinician, researcher, and writer. He is the director of the Mood Treatment Center in North Carolina, where he maintains a private practice combining medication and therapy along with evidence-based complementary and alternative treatments. Read More

Seven Lifestyle Interventions for Treatment-Resistant Depression

July 1, 2018

Chris Aiken, MD

Treatment-resistant depression (TRD) is not untreatable. The challenge is to keep hope alive and the patient engaged in recovery. “You deserve, and can expect, a full recovery,” I’ll often tell patients, “but we’re going to need more than medications to get you there.” I’ll then offer a choice: to either start weekly psychotherapy or make a lifestyle change—or both. Read More

A Primer on MAOIs

July 1, 2018

Here’s a common scenario. You have a patient who has tried three or four antidepressants over the years; all have been somewhat effective at least initially, but eventually that effectiveness waned. Read More

A CBT App for Refractory Depression

July 1, 2018

Xiaofan Li, MD.

This study tested a self-guided mobile app in patients with moderate to severe depression who had not responded to at least 1 antidepressant trial. The Japanese app, called Kokoro, used cartoon characters to present concepts from CBT, including self-monitoring, behavioral activation, and cognitive restructuring. Read More

Treatment-Resistant Depression: Some Introductory Tips

July 1, 2018

Chris Aiken, MD

Treatment-resistant depression (TRD) has a fairly low barrier of entry. Failure of 2 full antidepressant trials—lasting 6 weeks at a minimally effective dose—is enough to qualify. In this month’s issue of TCPR, we’ll highlight pharmacologic advances that are underutilized and debunk a few that are unlikely to be effective for TRD. Read More

Understanding Depressive Rumination

July 1, 2018

Edward Watkins, PhD

We often come across patients who seem stuck in a repetitive, negative style of thinking that we call rumination. Rumination is often associated with depression or anxiety, and when severe, it can seem akin to psychosis. Read More

Antidepressant Augmentation Strategies: A Basic Guide

July 1, 2018

Chris Aiken, MD

Learning Objectives, Treatment-Resistant Depression, TCPR, July/August 2018

June 25, 2018

After reading these articles, you should be able to… Read More

Medication Fact Book for Psychiatric Practice, Seventh Edition (2024) - Regular Bound Book
The updated 2024 reference guide covering the most commonly prescribed medications in psychiatry.
READ MORE

General Psychiatry
KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything
Read More

General Psychiatry
A Scam for Every Woman, Child, and Man: Part 2
1 in 3 Americans were victims of online scams in the past year. Even when you know your patient is being scammed, it is hard to pull them out. We speak with Cathy Wilson about...
Listen now